Literature DB >> 7054160

Chemical characterization of thymosin beta 4.

T L Low, A L Goldstein.   

Abstract

As part of our ongoing investigations on the endocrine thymus, we have isolated and purified to homogeneity a hormone-like peptide which we have termed thymosin beta 4. Thymosin beta 4 has Mr = 4982 and an isoelectric point of 5.1. The complete amino acid sequence of this polypeptide has been established by automated Edman degradation as well as by manual sequence analysis. Thymosin beta 4 is composed of 43 amino acid residues with acetylserine at the NH2 terminus. This molecule induces expression of terminal deoxynucleotidyl transferase in transferase-negative murine thymocytes in vivo and in vitro. It also exhibits ability to inhibit the migration of macrophages. Comparison of the sequence of thymosin beta 4 to other thymic hormones or other published protein sequences does not reveal any statistically significant relationship. Two helical regions were identified in the structure using data for prediction of protein conformation. It is proposed that thymosin beta 4 is one of the biologically active peptides present in thymosin fractions 5 and 5A which participate in the regulation, differentiation, and function of thymus-derived lymphocytes and may also act directly or indirectly on macrophages and perhaps other cells involved in cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

2.  Expression of thymosin beta-4 and related genes in developing human brain.

Authors:  M R Condon; A K Hall
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

3.  Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.

Authors:  M C Sanders; A L Goldstein; Y L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Evidence for the extranuclear localization of thymosins in thymus.

Authors:  O E Tsitsiloni; P P Yialouris; H Echner; W Voelter; A A Haritos
Journal:  Experientia       Date:  1992-04-15

5.  Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

Authors:  Gabriel Sosne; Ping Qiu; Patricia L Christopherson; Michelle Kurpakus Wheater
Journal:  Exp Eye Res       Date:  2007-01-23       Impact factor: 3.467

6.  Polarins: a novel group of immunologically active peptides.

Authors:  G Chipens; R Vegners; N Ievina; G Rosenthal
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

7.  Relationship of amino acid sequence to immunological activity - syntheses and structure-activity relationships of thymosinβ 4 family.

Authors:  T Abiko; H Sekino
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

8.  In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA.

Authors:  T-C Chao; L-C Chan; S-Y Ju; M-C Tang; C-Y Liu; P-M Chen; C-H Tzeng; Y Su
Journal:  Cancer Gene Ther       Date:  2014-08-15       Impact factor: 5.987

Review 9.  Thymosin β4 and cardiac regeneration: are we missing a beat?

Authors:  David C Gajzer; Jerome Balbin; Hina W Chaudhry
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

10.  Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK.

Authors:  Ping Qiu; Michelle Kurpakus Wheater; Yue Qiu; Gabriel Sosne
Journal:  FASEB J       Date:  2011-02-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.